6月龄至5岁儿童重症手足口病直接医疗费用及其影响因素
基于2012—2013年全国手足口病监测数据库,分层抽样685例5岁以下重症手足口病患儿进行电话随访。患儿直接医疗费用中位数(四分位距)为14250(10301,20600)元,病程长短和并发症严重程度影响总费用。
要点
- 重症手足口病患儿直接医疗费用中位数为14250元,经济负担较重。
- 合并肺出血/肺水肿或心肺衰竭者费用更高,中位数分别为20600元和20043元。
- 病程≥21天者直接医疗费用较病程≤5天者高20480元。
核心结论
- 重症手足口病直接医疗费用较高,总费用受病程和并发症严重程度影响。
研究设计与样本
- 采用分层抽样方法,从2012年1月1日至2013年12月31日全国手足口病监测数据库中收集重症病例数据,按肠道病毒A71型、柯萨奇病毒A16型和其他肠道病毒在全国重症病例中的病原分布参考抽样,覆盖七个地理区域。
- 通过结构化问卷进行全国电话访谈获取实验室确诊手足口病患者的直接医疗费用及并发症,排除无法回忆费用或并发症的病例后,最终685例纳入分析。
主要发现
- 685例患儿中,男性456例(66.6%),女性229例(33.4%);直接医疗费用P50(P25,P75)为14250(10301,20600)元。
- 127例(18.5%)诊断为重症手足口病伴呼吸系统疾病,38例(5.5%)为无菌性脑膜炎,378例(55.2%)为脑炎/脑干脑炎/急性弛缓性麻痹,53例(18.5%)为心肌炎,39例(5.7%)为肺出血/肺水肿,50例(7.3%)为心肺衰竭。
- 伴呼吸系统疾病者直接医疗费用中位数(四分位距)为12360(7313,16480)元,无菌性脑膜炎为13803(9064,19930)元,脑炎/脑干脑炎/急性弛缓性麻痹为14438(11000,20015)元,心肌炎为14800(8500,21218)元,肺出血/肺水肿为20600(12500,31130)元,心肺衰竭为20043(12772,28840)元(H=17.70,P<0.001)。
关键数值与推荐
- 华中地区重症手足口病患儿直接医疗费用较华北地区高7881(95%CI:3814-11949)元。
- 其他肠道病毒感染的重症手足口病患儿直接医疗费用较肠道病毒A71型感染低1987(95%CI:206-3769)元。
- 病程≥21天的重症手足口病患儿直接医疗费用较病程≤5天者高20480(95%CI:10985-29974)元。
- 肺出血/肺水肿和心肺衰竭的重症手足口病患儿直接医疗费用分别较呼吸系统疾病者高7874(95%CI:3723-12026)元和9855(95%CI:328-19382)元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To estimate the direct medical cost of severe hand, foot and mouth disease (HFMD) in patients aged less than five years. Methods: A stratified sampling method was used to collect data on severe HFMD cases reported in the National HFMD surveillance database between Jan 1, 2012, and Dec 31, 2013. The sampling was referenced with the national aetiologic distribution of Enterovirus A71 (EV-A71), Coxsackievirus A16 (CV-A16) and other Enteroviruses (OEV) for severe HFMD cases and the included cases were distributed among seven geographic regions (Northeast, North China, Northwest, Central China, Southwest, East China and South China). A nationwide telephone interview using a structured questionnaire was conducted to obtain the direct medical cost and any complications that occurred in patients during the outbreak of laboratory-confirmed HFMD. After excluding the cases who could not recall their medical expenses or complications, a total of 685 cases were included in the analysis. Kruskal-Wallis H test was used to analyze the differences among patients who reported different complications. Multiple linear regression with bootstrap analysis of 500 replicates was used to explore the factors that influenced the direct medical costs. Results: Of 685 patients analyzed, 456 (66.6%) were male and 229 (33.4%) were female. The direct medical costs P50 (P25, P75) were 14 250 (10 301, 20 600) Yuan. In total, 127 (18.5%) patients were diagnosed with severe HFMD patients with respiratory disease, 38 (5.5%) patients were diagnosed with aseptic meningitis, and 378 (55.2%) with encephalitis/brainstem encephalitis/acute flaccid paralysis. Furthermore, 53 (18.5%) patients were diagnosed with myocarditis, 39 (5.7%) with pulmonary hemorrhage/pulmonary edema and 50 (7.3%) with cardiopulmonary failure. The median (interquartile range) direct medical costs were 12 360 (7 313, 16 480) Yuan for severe HFMD patients with respiratory disease, 13 803 (9 064, 19 930) Yuan for aseptic meningitis, 14 438 (11 000, 20 015) Yuan for encephalitis/brainstem encephalitis/acute flaccid paralysis, 14 800 (8 500, 21 218) Yuan for myocarditis, 20 600 (12 500, 31 130) Yuan for pulmonary hemorrhage/pulmonary edema, and 20 043 (12 772, 28 840) Yuan for cardiopulmonary failure (H=17.70, P<0.001). The results of multiple linear regression with bootstrap analysis revealed that the direct medical cost for severe HFMD patients from Central China was 7 881 (95% CI: 3 814-11 949) Yuan higher than that of North China; severe HFMD patients diagnosed with OEV had direct medical costs of 1 987 (95%CI: 206-3 769) Yuan less those associated with EV-A71; severe HFMD patients whose duration of illness was ≥21 d had 20 480 (95% CI: 10 985- 29 974) Yuan higher direct medical costs those whose illness lasted ≤5 d; the direct medical costs for severe HFMD patients with pulmonary hemorrhage/pulmonary edema and cardiopulmonary failure were 7 874 (95%CI: 3 723-12 026) and 9 855 (95% CI: 328- 19 382) Yuan higher, respectively, than that associated with respiratory disease. Conclusion: The direct medical costs associated with severe HFMD were found to be substantial. The total cost was affected by the duration of the illness and the severity of any complications.
引用
- Zheng YM, Yang J, Liao QH, et al. [Direct medical costs and influencing factors in severe hand, foot and mouth disease in children aged between six months and five years old]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017. PMID: 28056277. doi:10.3760/cma.j.issn.0253-9624.2017.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。